New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 15, 2014
08:41 EDTNEONeoGenomics 7M share Spot Secondary priced at $4.60
The deal size was increased to 7M shares from 5M shares and was priced at $4.60. William Blair acted as lead book running manager for the offering.
News For NEO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 25, 2015
08:40 EDTNEONeoGenomics reimbursement rates could rebound, says Roth Capital
Roth Capital expects reimbursement rates for NeoGenomics' tests to rebound in 2H15, since the firm believes, based on data, that most labs are probably performing the tests below costs. The firm keeps a $7 price target and Buy rating on NeoGenomics.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use